All posts by minerick

Summer Writing Meetups: Fridays at noon through the summer

The research development office will be hosting Summer Writing Meetups at the Library every Friday at noon through the summer. These meet ups will start on May 25, 2018. Here’s a link to the calendar invite  and can also be seen on the RD Toolkit home page. These are open to all. Feel free to share and encourage colleagues at any career stage, as well as postdocs, grad students, and proposal support staff.


Side article on balancing work with home…

During my ELATE training, I met Sabina Nawaz. One of her articles I thought was worth sharing.

As a leader, you probably juggle many things at work and at home. You’re not alone. Most executives I coach struggle with balancing parenting and work duties. They worry that they aren’t spending enough time with their children, and they’d like to help their children learn from their experience and avoid mistakes they’ve made.
What if you could maximize your time by making progress on work challenges while spending time with your children and helping them learn important skills in the process? Given my own challenges with balancing multiple priorities, I’ve learned a few ways to make the most of my time with both work and family, and I’ve shared these tips with my clients, many of whom have adopted similar practices. And the tips don’t take any additional time. In fact, you can increase time with your children without losing work time or adding more to your already full plate. By doing things a bit differently, you benefit your task list, your children, and yourself.
Continue reading here

NIH RFPs

Requests for Applications

  • Collaborative Network to Advance Deprescribing Research for Older Adults with Multiple Chronic Conditions (R24 Clinical Trial Optional)
    (RFA-AG-19-005)
    National Institute on Aging
    Application Receipt Date(s): October 18, 2018, by 5:00 PM local time 

  • Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 – Clinical Trial Not Allowed)
    (RFA-HD-19-018)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): August 9, 2018, by 5:00 PM local time

  • Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers (UM1 Clinical Trial Not Allowed )
    (RFA-HL-19-009)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): August 2, 2018, by 5:00 PM local time

  • Limited Competition: Cardiothoracic Surgical Trials Network (CTSN) Data Coordinating Center (U01 Clinical Trial Required)
    (RFA-HL-19-010)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): August 2, 2018, by 5:00 PM local time

  • NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 – Clinical Trial Optional)
    (RFA-HL-19-017)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): July 27, 2018; July 9, 2019; July 9, 2020, by 5:00 PM local time

  • NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
    (RFA-HL-19-018)
    National Heart, Lung, and Blood Institute
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): July 27, 2018; July 9, 2019; July 9, 2020, by 5:00 PM local time

  • BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs – eTeamBCP (U01 Clinical Trial Not Allowed)
    (RFA-NS-18-029)
    Application Receipt Date(s): July 23, 2018 and June 10, 2019 by 5:00 PM local time

  • Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 – Independent Clinical Trial Not Allowed)
    (RFA-OD-18-005)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019, by 5:00 PM local time

  • Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 – Independent Clinical Trial Required)
    (RFA-OD-18-006)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019, by 5:00 PM local time

  • Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 – Independent Clinical Trial Not Allowed)
    (RFA-OD-18-007)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019), by 5:00 PM local time

  • Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 – Independent Clinical Trial Required)
    (RFA-OD-18-008)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019 , by 5:00 PM local time

Program Announcements

  • Exposure Analysis Services for the Environmental Influences on Child Health Outcomes (ECHO) Program (Admin Supp – Clinical Trial Not Allowed)
    (PA-18-783)
    National Institute of Environmental Health Sciences
    Application Receipt/Submission Date(s): June 15, 2018, by 5:00 PM local time

  • The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 – Clinical Trial Not Allowed)
    (PA-18-784)
    National Heart, Lung, and Blood Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time

  • Wearable Alcohol Biosensors (STTR) (R41/R42- Clinical Trial Optional)
    (PA-18-785)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time

  • Wearable Alcohol Biosensors (SBIR) (R43/R44- Clinical Trial Optional)
    (PA-18-786)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time

  • Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)
    (PAR-18-787)
    National Institute of Dental and Craniofacial Research
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time

  • Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed)
    (PAR-18-788)
    National Institute of Dental and Craniofacial Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time

  • Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed)
    (PAR-18-789)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): August 21, 2018, March 19, 2019; August 21, 2019, March 19, 2020; August 21, 2020, March 19, 2021, by 5:00 PM local time 

national research symposium for outstanding undergraduate researchers

The Department of Chemical and Biomolecular Engineering at NC State University is hosting its second annual “Future Leaders in Chemical Engineering“, a national research symposium for outstanding undergraduate researchers in Chemical Engineering.  The event will be held October 21-22, 2018.  Travel expenses for those selected will be covered. In addition to receiving recognition, awardees will get to meet peers, present their research, and learn more about graduate school.

Additional information can be found in the attached flyer and website (https://www.cbe.ncsu.edu/future-leaders-in-chemical-engineering/ ). Applications are due September 13th.

I would greatly appreciate if you would circulate the attached flyer to faculty advisors and undergraduates who might have interest in applying.

Thank you.

Peter

— ************************************************** Peter S. Fedkiw, Department Head Alumni Distinguished Graduate Professor Department of Chemical and Biomolecular Engineering Room 2006A, Engineering Building 1 911 Partners Way, Box 7905 NC State University Raleigh, NC 27695-7905 Phone: 919-515-3572 Fax: 919-515-3465 e-mail: fedkiw@ncsu.edu Department website: www.che.ncsu.edu


NSF RFPs

 Full Proposal Deadline Date: June 14, 2018

Program Guidelines: NSF 18-550  The NSF SBIR program focuses on transforming scientific discovery into products and services with commercial potential and/or societal benefit. Unlike fundamental research, the NSF SBIR program supports startups and small businesses in the creation of innovative, disruptive technologies, getting discoveries out of the lab and into the market.The NSF SBIR Program … More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505233&WT.mc_id=USNSF_44&WT.mc_ev=click

 

 Full Proposal Deadline Date: June 14, 2018

Program Guidelines: NSF 18-551  The NSF STTR program focuses on transforming scientific discovery into products and services with commercial potential and/or societal benefit. Unlike fundamental research, the NSF STTR program supports startups and small businesses in the creation of innovative, disruptive technologies, getting discoveries out of the lab and into the market.The NSF STTR Program …  More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505362&WT.mc_id=USNSF_44&WT.mc_ev=click

 

 Full Proposal Deadline Date: June 13, 2018
Program Guidelines: NSF 18-553 Lack of essential observations from space is currently a major limiting factor in many areas of geospace and atmospheric research. Recent advances in sensor and spacecraft technolo­gies make it feasible to obtain key measurements from low-cost, small satellite missions. A particularly promising aspect of this development is the prospect for obtaining multi-point observations in space that are critical for addressing many outstanding problems in space and atmospheric sciences. …More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503172&WT.mc_id=USNSF_39&WT.mc_ev=click

 

NSF Program Announcements and Information items.

Molecular Separations

Disability and Rehabilitation Engineering

Cellular and Biochemical Engineering

Fluid Dynamics

Electrochemical Systems

Biosensing

Biological and Environmental Interactions of Nanoscale Materials

Environmental Engineering

Environmental Sustainability

Engineering of Biomedical Systems


Encourage your students to apply for the DEBUT Challenge!

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) and VentureWell hold the Design by Biomedical Undergraduate Teams (DEBUT) challenge which recognizes undergraduate excellence in biomedical innovation. DEBUT is open to undergraduate student teams working on innovative solutions to health and clinical problems.

Strong DEBUT submissions will demonstrate a mastery of analytical and design skills and capabilities, the ability to manage the product development process, work effectively in teams, and technical communication skills.

Submissions will be judged on the following criteria:

  • Significance of the problem being addressed
  • Impact of the proposed solution on potential users and clinical care
  • Innovative design
  • Working prototype

Additional prizes will be awarded to entries that also demonstrate:

  • Market potential and economic feasibility
  • Patentability

Read more about the guidelines and the 2017 DEBUT winners.

Encourage your students to apply today! Total prizes of $65K will be awarded. Applications are due Wednesday, May 31.

    Learn More    

AAAS Science and Technology Policy Fellowships

The annual faculty trip to Washington DC was this week.  In addition to visiting NSF, Federal Science Partners, and NIH, we were able to visit AAAS (American Association for the Advancement of Science) offices.   We met Dr. Jennifer Pearl who is the Director of the Science & Technology Policy Fellowships program.   I’d highly recommend that you consider applying for one of these for your next sabbatical and/or encourage your PhD grads & postdocs to apply.  Assignments are made across the Executive, Judicial, and Legislative branches of government. A common assignment for faculty is in NSF, NIH, NIST, DoE, DoD, etc. in positions providing perspective reports, new funding initiatives, and related.

Applications are due in Nov for assignments beginning 9-10 months later (Sept).

Details at https://www.aaas.org/program/science-technology-policy-fellowships

This is definitely a pay it forward type of activity!


NHLBI SBIR Phase IIB Bridge & Small Market Awards

Accepting applications beginning June 27, 2018

NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional).

The Bridge Award supports Phase II SBIR or STTR awardees to advance NHLBI mission-related products to regulatory approval and eventual commercialization. The program promotespartnerships between SBIR/STTR Phase II awardees and third-party investors and/or strategic partners.

Read the full announcement: RFA-HL-19-017

NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional).

The Small Market Award supports Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends.

Read the full announcement: RFA-HL-19-018
Due Dates:

Application: July 27, 2018; by 5:00 PM

Letter of Intent (optional but encouraged): June 27, 2018

Applicants are strongly encouraged to contact the program representative(s) listed in the announcement prior to submitting a proposal.

More information is available in the full Funding Opportunity Announcements RFA-HL-19-017RFA-HL-19-018 and by contacting

Gary Robinson, PhD 
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7978
Email: gary.robinson@nih.gov


Department of Defense Neurofibromatosis Research Program Funding Opportunities for Fiscal Year 2018 (FY18)

FY18 NFRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

Areas of Emphasis: The NFRP encourages applications that specifically address the critical needs of the NF community in one or more of the FY18 Areas of Emphasis.  Not all Areas of Emphasis are applicable to each award mechanism offered by the FY18 NFRP.  If the proposed research project does not address one of the FY18 Areas of Emphasis, justification that the proposed research project addresses an important problem related to NF research and/or patient care should be provided.

  • Health services research

○                    Evidence-based best clinical practices

○                    Implementation and access to NF-specific health care

○                    Utilization of technology and informatics

  • Heterogeneity of neurofibromas and other NF-related tumors
  • Nontumor manifestations

○                    Cognitive, behavior, sleep, pain, hypotonia, communication, etc., including quality of life measures, self-reported and underreported manifestations

  • Novel disease and treatment response markers using genomics, epigenetics, systems biology, metabolomics, or similar approaches

○                    Transition from benign to malignant

  • Nutritional, environmental, and other modifiers of NF
  • Post-adolescent manifestations
  • Preclinical efficacy studies
  • Target identification, drug discovery, targeted and immunotherapies

http://cdmrp.army.mil/funding/nfrp

Clinical Trial Award – Letter of Intent due 7/26/18

  • Independent investigators at or above the level of Assistant Professor (or equivalent)
  • Fund Phase 0, I, or II clinical trials relevant to NF and/or schwannomatosis; combinations of phases are permitted.
  • Funding must support a clinical trial and may not be used for preclinical studies.
  • Scientific rationale and preliminary data required for Phase I, II clinical trial applications.
  • Maximum funding of $800,000 for direct costs (plus indirect costs)
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs) for applications including a Collaborator
  • Maximum period of performance is years

Exploration – Hypothesis Development Award – Letter of Intent due 7/26/18

  • All academic levels (or equivalent)
  • Fund the initial exploration of innovative, high-risk, high-gain and potentially. groundbreaking concepts in NF research
  • Projects involving human subjects or human biological substances must be exempt under 32 CFR 219.101(b) or eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110.
  • Preliminary and/or published data is encouraged but not required.
  • Clinical trials not allowed
  • Maximum funding of $100,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years

Investigator-Initiated Research Award – Letter of Intent due July 26, 2018

  • Independent investigators at or above the level of Assistant Professor (or equivalent) and must plan to commit at least a 10% level of effort for each budget period throughout the entirety of the award
  • Fund highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care.
  • Optional Feature: Applications that include a Qualified Collaborator who meets criteria identified in the announcement may apply for a higher level of funding.
  • Preliminary and/or published data required.
  • Clinical trials not allowed.
  • Maximum funding of $525,000 for direct costs (plus indirect costs)
  • Maximum funding of $575,000 for direct costs (plus indirect costs) for applications including an Optional Qualified Collaborator
  • Maximum period of performance is 3 years

New Investigator Award – Letter of Intent due July 26, 2018

  • Independent investigators at or below the level of Assistant Professor (or equivalent) or an established investigator at or above the level of Assistant Professor seeking to transition into a career in NF research
  • Support the continued development of promising independent investigators and/or the transition of established investigators into a career in the field of NF research
  • Experience in NF research is allowed, but not required
  • Preliminary and/or published data required
  • Clinical trials not allowed
  • Maximum funding of $450,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

Early Investigator Research Award – Letter of Intent due July 26, 2018

  • Postdoctoral Ph.D. or M.D. PIs:
  • Must have successfully defended a doctoral thesis or possess an M.D. degree and
  • Have at least 3 years and up to 6 years of consecutive postdoctoral fellowship
  • Supports research opportunities focused on NF for individuals in the early stages of their careers.
  • PIs must have a designated mentor who is an experienced NF researcher
  • Maximum funding of $200,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the NFRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507
help@reBrap.org


Quotes needed for purchases of $10,000 to $49,999

The federal regulations, 2 CFR 200, Uniform Guidance (UG), for external sponsored projects has been updated. Although much of the UG took effect on Dec. 26, 2014, the government delayed implementation of the procurement sections.

Procurement guidance focuses on increased competition and transparency in the procurement process. The UG section 200.320(a) and (b), which address required documentation for purchases on external sponsored projects, warrant changes in Michigan Tech’s current procurement practices.

Effective July 1, purchases of $10,000 to $49,999 on external-sponsored projects require two or more quotes from qualified suppliers. A listing of all procurement thresholds is available on the Purchasing website. It is of particular importance to note that reallocations of expenditures to external sponsored projects will not be allowable if two or more informal quotes were not attained at the time of purchase. We encourage applying these guidelines now as it may prove to be beneficial for the PI and the department.